In the pharmaceutical and biotech industry, the term Gross-to-Net (GTN) has developed into more than just the financial management and forecasting of manufacturer’s discounts. The GTN umbrella encompasses all aspects of revenue management, reporting, and analytics.

To add value to the industry, the Revenue Analytics Collaborative (RAC) began surveying its members seven years ago to document GTN successful practices and trends. Needless to say, a lot has changed in the life sciences industry since we began RAC surveys in 2015.

Download now!